secwatch / observer
8-K filed May 5, 2026, 7:59 PM ET ticker INSP CIK 0001609550
other material confidence high sentiment neutral materiality 0.55

Inspire Medical shareholders approve declassification, 2.6M-share increase to equity plan

Inspire Medical Systems, Inc.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Inspire Medical Systems, Inc.: Amendment to Certificate of Incorporation to phase out classified board structure and provide for annual election of all directors beginning with 2029 annual meeting, effective May 1, 2026 (effective 2026-05-01).

Change
charter amendment
Effective
2026-05-01
Exact text from the filing
On May 1, 2026, the Company filed a Certificate of Amendment to the Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware, which became effective upon filing.
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.7

Inspire Medical Systems, Inc. shareholders approved Approval of an amendment and restatement of the Inspire Medical Systems, Inc. 2018 Incentive Award Plan (A&R 2018 Plan) at the 2026-04-30 meeting.

Proposal
equity plan
Outcome
passed
Meeting
2026-04-30
Exact text from the filing
As reported below under Item 5.07 of this Current Report on Form 8-K (this “Current Report”), on April 30, 2026, Inspire Medical Systems, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”), at which the Company’s stockholders approved an amendment and restatement of the Inspire Medical Systems, Inc. 2018 Incentive Award Plan (such amended and restated plan, the “A&R 2018 Plan”).
View on SEC.gov

42 governance changes filed in the last 30 days. Browse all governance changes →

Inspire Medical Systems, Inc. filing history →

Source: SEC EDGAR
accession 0001609550-26-000026
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.